Table 2. mITT and Per protocol analysis at end of treatment.
4FDC arm | LF arm | |||||
mITT Cohort | N | % | N | % | Difference | (90%CI) |
Unfavourable Result | 61 | 13.3% | 69 | 14.8% | ||
Favourable Result (cure) | 398 | 86.7% | 396 | 85.2% | 1.55% | (-2.22; 5.32) |
Total | 459 | 100.0% | 465 | 100% | ||
4FDC arm | LF arm | |||||
Per Protocol Cohort | N | % | N | % | Difference | (90%CI) |
Unfavourable Result | 4 | 1.1% | 11 | 3.1% | ||
Favourable Result (cure) | 359 | 98.9% | 345 | 96.9% | 2.0% | (0.13; 3.8) |
Total | 363 | 100.0% | 356 | 100.0% |